8/28/09 update
The Bulls controlled the game most of the week and at Friday's close, the Nasdaq Composite Index was up 29.09% CYTD, or Contest Year To Date, (vs. up 28.59% CYTD a week ago), the Nasdaq Biotech Index was up 13.55% CYTD (vs. up 12.69% CYTD a week ago), while the Contest median was up 25.75% CYTD (vs. up 24.74% CYTD a week ago).
Thanks again to OGXI, RKRW's portfolio had a huge week, substantially cutting into the lead of GENE's portfolio. MIKE's portfolio held on to third place.
The week's closing CYTD percentages are: GENE up 151.57%, RKRW up 132.12%, MIKE up 107.76%.
At Friday's close, 27 of the 32 Contest portfolios were in the black and 22 of the 32 were beating the NBI.
Portfolio adjustments:
1) I neglected to adjust for the MYGN 1 for 4 distribution of MYRX on 6/30. My spreadsheet now reflects that distribution for the two portfolios that hold MYGN (SJEMM & THEOX).
2) I will try to do the MEDX buyout adjustment soon.
Have a wonderful weekend folks!
Below is the Top Ten list on 8/28/09:
8/28/09
Rank Name Profit/Loss
1 GENE 151,571
2 RKRW 132,119
3 MIKE 107,762
4 NIGEL 77,424
5 MOPGCW 68,280
6 ASHLEY 59,649
7 BULBA 58,599
8 ENZYME 53,190
9 SCARAM 52,580
10 GEORGIA 52,532
(All corrections, especially adjustments for splits, greatly appreciated.) |
